Tony Fonk | CEO
SpotSee

Tony Fonk is the President and Chief Executive Officer of SpotSee, a global leader in condition-monitoring technologies that help organizations protect high-value and sensitive products throughout the supply chain. Since joining SpotSee in 2015, Tony has led the company’s evolution from a provider of impact and environmental indicators into a leading innovator in connected monitoring solutions, helping pharmaceutical manufacturers, healthcare providers, and logistics organizations gain greater visibility into the conditions that affect product quality and integrity. With more than 25 years of international leadership experience, Tony has built a career around driving growth through customer-focused innovation, operational excellence, and strategic market development. Prior to SpotSee, he held senior leadership roles with Stock Building Supply, Ingersoll Rand, and Johns Manville, a Berkshire Hathaway company, where he led businesses, product portfolios, and market strategies across multiple industries and global regions.  Under Tony’s leadership, SpotSee has become a trusted partner to pharmaceutical and life sciences organizations seeking to protect temperature-sensitive products and ensure product quality from manufacturing through administration. In 2026, SpotSee was recognized by RXinsider as a Pharmacy500 Company, honoring organizations that have made a significant impact on dispensing pharmacies and pharmaceutical supply chain operations.  Tony holds a B.S. from the University of Kansas, has completed executive education programs at Harvard Business School, and is a certified Lean Six Sigma Black Belt.  At the World Vaccine Congress Europe, Tony will present“Closing the Gap: Vaccine Integrity Through the Last Mile,” sharing insights on how condition-monitoring technology, real-time visibility, and data-driven supply chain practices can help preserve vaccine efficacy, reduce risk, and strengthen confidence in vaccine delivery all the way to the point of care.